Robert E. Gagnon

Insider Reports History

Location
Needham, MA
Signature
/s/ Amy Rabourn, by Power of Attorney
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Robert E. Gagnon:

Form 4 holding Director

Bone Biologics Corp

Security class
Non-Employee Stock Option
Shares / value
62,894
Estimated value
$49,057
Report date
04 Jun 2025
Price
$0.7800
Ownership
Direct
Underlying class
Common Stock
Underlying amount
62,894
Form 4 holding Chief Financial Officer

Opus Genetics, Inc.

Security class
Employee Stock Option (right to buy)
Shares / value
250,000
Estimated value
Report date
02 Sep 2025
Price
Ownership
Direct
Underlying class
Common Stock
Underlying amount
Form 4 holding Director

Verastem, Inc.

Security class
Stock Option (right to buy)
Shares / value
12,500
Estimated value
Report date
22 May 2025
Price
Ownership
Direct
Underlying class
Common Stock
Underlying amount

Insider Reports Filed by Robert E. Gagnon

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Here you can make detailed settings or revoke your consent (in part if necessary) with effect for the future. For further information, please refer to our Privacy Policy .